Skip to content

MOVE

Movano, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$8.20
+2.37%
Ask drillr
  • Oct 14, 2026, 20:44 UTC

    Corvex, Inc. entered into an At-the-Market Sales Agreement with Chardan Capital Markets LLC to offer and sell shares of its common stock from time to time.

  • Oct 13, 2026, 08:45 UTC

    Whitbread Plc scheduled a general meeting for November 9 for shareholders to vote on Corvex's proposal to appoint James Gemmel to Whitbread Plc's board.

  • Oct 13, 2026, 07:09 UTC

    Whitbread Plc asked shareholders to reject Corvex, Inc.’s demand for a board seat.

  • Sep 30, 2026, 13:40 UTC

    Corvex, Inc. launched Corvex Token Factory, a serverless inference platform for open-weight AI models with zero data retention by default and API-based access.

  • Sep 4, 2026, 20:32 UTC

    Corvex, Inc. reported combined results for H1 2026 with revenue of $4,312 and a net loss of $26,155, including a net loss per share of $0.94, following an acquisition with an estimated purchase price of $581,955.

  • Aug 31, 2026, 11:45 UTC

    Corvex, Inc. secured a $33 million private placement to fund its data center expansion, increasing pro forma cash and cash equivalents to approximately $55 million.

  • Aug 31, 2026, 11:45 UTC

    Corvex, Inc. announced a data center expansion that will increase its critical IT capacity from approximately 1.5 MW to approximately 8 MW by year-end 2026, with a right of first refusal on an additional 12.5 MW expansion at its Midwest site, potentially reaching over 20 MW total.

  • Aug 14, 2026, 00:00 UTC

    Corvex, Inc. reported Q2 2026 revenue of $3.8 million, a net loss of $12.8 million, and diluted EPS of -$5.12, with adjusted EBITDA of -$3.2 million.

  • Jul 7, 2026, 00:00 UTC

    Corvex, Inc. exchanged its outstanding Series C Non-Voting Convertible Preferred Stock for newly issued Series D Non-Voting Convertible Preferred Stock, which was then converted into 4,752,244 shares of the company's common stock on July 7, 2026.